ROLE OF EARLY VITRECTOMY IN THE TREATMENT OF FUNGAL ENDOPHTHALMITIS
- PMID: 28541964
- DOI: 10.1097/IAE.0000000000001727
ROLE OF EARLY VITRECTOMY IN THE TREATMENT OF FUNGAL ENDOPHTHALMITIS
Abstract
Purpose: To study whether immediate pars plana vitrectomy at the time of sampling vitreous for culture alter the visual and structural outcomes in fungal endophthalmitis.
Methods: Surgical results of 66 consecutive patients with culture-positive fungal endophthalmitis attending a tertiary eye care hospital in eastern India were analyzed. Based on the timing of vitrectomy, they were divided into 2 groups: Group 1-immediate vitrectomy (n = 31) and Group 2-diagnostic vitrectomy alone (n = 35) as the first-line intervention. The demographics, clinical features, and visual and structural outcomes were compared between the groups.
Results: The proportion of postoperative (54.83 vs. 51.42%), traumatic (29.03 vs. 34.28%), and endogenous (16.12 vs. 14.28%) endophthalmitis and clinical signs such as pain (54.83 vs. 60%), lid edema (48.38 vs. 48.57%), conjunctival congestion (87.09 vs. 94.28%), and corneal involvement (87.09 vs. 80%) in Groups 1 and 2, respectively, were comparable. Logarithm of the minimum angle of resolution vision improvement in Group 1 was significant (P = 0.0278) though there was no statistically significant difference in posttreatment vision between the groups (P = 0.322). Phthisis was seen in 25.8% in Group 1 and 25.7% in Group 2 (P = 0.993). Aspergillus species was the most common fungal pathogen isolated. Early vitrectomy plus intravitreal antifungals in a subset of clinically suspected fungal endophthalmitis resulted in statistically significant visual improvement over diagnostic vitrectomy plus intravitreal antifungals (P = 0.013).
Conclusion: A strong clinical suspicion that translates into early vitrectomy plus intravitreal antifungal antibiotics leads to favorable visual and structural outcomes. A long wait till microbiological confirmation to institute antifungal therapy may result in poorer outcome.
Similar articles
-
Characteristics and Outcomes of Endogenous Endophthalmitis: Eight-Year Experience at a Tertiary Care Center.Ophthalmol Retina. 2019 Jan;3(1):61-72. doi: 10.1016/j.oret.2018.08.009. Epub 2018 Sep 6. Ophthalmol Retina. 2019. PMID: 30929817
-
Clinical Factors, Treatment Selection, and Outcomes in Postcataract Fungal Endophthalmitis from Contaminated Viscoelastics.Ophthalmol Retina. 2024 May;8(5):473-480. doi: 10.1016/j.oret.2023.11.004. Epub 2023 Nov 19. Ophthalmol Retina. 2024. PMID: 37989464
-
Exogenous fungal endophthalmitis: microbiology and clinical outcomes.Ophthalmology. 2008 Sep;115(9):1501-7, 1507.e1-2. doi: 10.1016/j.ophtha.2008.02.027. Epub 2008 May 16. Ophthalmology. 2008. PMID: 18486220
-
Endogenous fungal endophthalmitis.Int Ophthalmol Clin. 1996 Summer;36(3):147-62. doi: 10.1097/00004397-199603630-00014. Int Ophthalmol Clin. 1996. PMID: 8989607 Review.
-
Endogenous endophthalmitis in children and adolescents: Case series and literature review.Indian J Ophthalmol. 2019 Jun;67(6):795-800. doi: 10.4103/ijo.IJO_710_18. Indian J Ophthalmol. 2019. PMID: 31124489 Free PMC article. Review.
Cited by
-
Vitrectomy for endophthalmitis: 5-year study of outcomes and complications.BMJ Open Ophthalmol. 2020 Mar 24;5(1):e000423. doi: 10.1136/bmjophth-2019-000423. eCollection 2020. BMJ Open Ophthalmol. 2020. PMID: 32258421 Free PMC article.
-
Sudden vision loss heralding COVID-19-associated aspergillosis. Report of 2 cases.Am J Ophthalmol Case Rep. 2023 Aug 24;32:101924. doi: 10.1016/j.ajoc.2023.101924. eCollection 2023 Dec. Am J Ophthalmol Case Rep. 2023. PMID: 37860668 Free PMC article.
-
Endophthalmitis at a tertiary referral center: Characteristics and treatment outcomes over three decades.Front Cell Dev Biol. 2022 Aug 8;10:952375. doi: 10.3389/fcell.2022.952375. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 36003150 Free PMC article.
-
A 14-Year Retrospective Analysis of Endogenous Endophthalmitis in a Tertiary Referral Center of Southern Thailand.J Ophthalmol. 2020 Dec 15;2020:6689081. doi: 10.1155/2020/6689081. eCollection 2020. J Ophthalmol. 2020. PMID: 33489338 Free PMC article.
-
Aspergillus Endophthalmitis: Clinical Presentations and Factors Determining Outcomes.Asia Pac J Ophthalmol (Phila). 2020 Jan-Feb;9(1):9-13. doi: 10.1097/01.APO.0000617928.43993.7e. Asia Pac J Ophthalmol (Phila). 2020. PMID: 31990739 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous